Autoimmune Haemolytic Anaemia following ChAd Ox 1 nCoV-19 in Haemodialysis

J Assoc Physicians India. 2022 Jan;70(1):11-12.

Abstract

Autoimmune haemolytic anaemia (AIHA) is caused by autoantibodies that react with self-red blood cells (RBCs) and cause them to be destroyed with or without complement mediated mechanism. Its clinical presentation is heterogeneous, ranging from asymptomatic to severe forms with fatal outcomes, also it can be either idiopathic or secondary to a coexisting disorder. We report an elderly gentleman on haemodialysis, who presented with severe haemolytic anaemia after one month of first dose of ChAd Ox 1 nCoV-19 vaccine (viral vector vaccine) for SARS- CoV - 2, who also had asymptomatic COVID 19 infection around 6 months prior to vaccination. This is the first reported case of AIHA following COVISHIELD vaccine and till now there are no other reported cases from India.

MeSH terms

  • Aged
  • Anemia, Hemolytic, Autoimmune* / diagnosis
  • Anemia, Hemolytic, Autoimmune* / etiology
  • Anemia, Hemolytic, Autoimmune* / therapy
  • COVID-19*
  • ChAdOx1 nCoV-19
  • Chad
  • Humans
  • Renal Dialysis
  • SARS-CoV-2

Substances

  • ChAdOx1 nCoV-19